acetylcarnitine has been researched along with dapagliflozin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dautzenberg, B; de Ligt, M; Esterline, R; Gemmink, A; Havekes, B; Hesselink, MKC; Hoeks, J; Jorgensen, JA; Kersten, S; Kornips, E; Koves, TR; Muoio, DM; Op den Kamp, YJM; Oscarsson, J; Pava, DA; Phielix, E; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB | 1 |
1 trial(s) available for acetylcarnitine and dapagliflozin
| Article | Year |
|---|---|
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism.
Topics: Acetylcarnitine; Amino Acids; Cross-Over Studies; Diabetes Mellitus, Type 2; Fatty Acids; Glucose; Humans; Lipids; Muscle Fibers, Skeletal; Muscle, Skeletal; Sodium-Glucose Transporter 2 Inhibitors | 2022 |